You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Drugs Containing Excipient (Inactive Ingredient) FD&C BLUE NO. 2


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing FD&C BLUE NO. 2 excipient, and estimated key patent expiration / generic entry dates

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: FD&C Blue No. 2

Introduction to FD&C Blue No. 2

FD&C Blue No. 2, also known as indigotine, is a colorant widely used in various industries, including pharmaceuticals, food, and cosmetics. It is approved by the FDA for use in drug dosage forms such as tablets and capsules, as well as in food and cosmetic products[1][4].

Regulatory Framework

The FDA plays a crucial role in the regulation of color additives, including FD&C Blue No. 2. The agency ensures that these colorants meet specific safety and quality standards before they are approved for use. This regulatory oversight is essential for maintaining consumer safety and trust in the products that contain these colorants[1][4].

Market Demand and Growth

Pharmaceutical Excipients Market Outlook

The global pharmaceutical excipients market, which includes colorants like FD&C Blue No. 2, is projected to grow significantly. From USD 10.0 billion in 2023, the market is expected to reach USD 13.9 billion by 2028, driven by a Compound Annual Growth Rate (CAGR) of 6.8%. This growth is largely attributed to the increasing demand for generic drugs and patient-centric formulations[3].

Specific Demand for FD&C Blue No. 2

FD&C Blue No. 2 is widely used in pharmaceutical formulations, particularly in tablets and capsules. The demand for this colorant is closely tied to the overall growth in the pharmaceutical industry. According to FDA reports, the quantity of FD&C Blue No. 2 certified in the second quarter of the fiscal year 2024 was 61,262.02 pounds, with a recapitulation of 183,489.53 pounds from October to March[2].

Applications in Pharmaceuticals

Medications Containing FD&C Blue No. 2

FD&C Blue No. 2 is used in a variety of medications, including but not limited to:

  • Alprazolam
  • Amphetamine and Dextroamphetamine Extended Release
  • Clonazepam
  • Cyclobenzaprine Hydrochloride
  • Doxycycline Hyclate
  • Hydroxyzine Pamoate
  • Morphine Sulfate Extended-Release
  • Oxycodone Hydrochloride
  • Sertraline Hydrochloride
  • Tamsulosin Hydrochloride[1].

FD&C Blue No. 2 Aluminum Lake

In addition to its straight form, FD&C Blue No. 2 is also used in the form of an aluminum lake, which is particularly stable and suitable for tablet coatings. Medications such as Amphetamine and Dextroamphetamine Extended Release, Chlorpromazine Hydrochloride, and Paroxetine Extended-Release contain FD&C Blue No. 2 Aluminum Lake[4].

Market Drivers

Increasing Demand for Generic Drugs

The growing demand for generic drugs is a significant driver for the pharmaceutical excipients market, including colorants like FD&C Blue No. 2. Generic drugs are cheaper and have a higher volume of sales, which increases the demand for excipients used in their formulation[3].

Patient-Centric Formulations

There is a growing emphasis on patient-centric formulations, which often require specialized excipients to enhance the appearance, taste, and overall acceptability of the medication. This trend fuels the demand for high-quality colorants like FD&C Blue No. 2[3].

R&D Investments and Collaborations

Increased investments in research and development (R&D) for novel excipients and collaborations between pharmaceutical companies and excipient manufacturers are also driving the market. These efforts lead to the development of new and improved excipients, including colorants[3].

Market Restraints

Regulatory Stringency

The pharmaceutical excipients market, including FD&C Blue No. 2, faces challenges due to stringent regulatory requirements. The FDA and other regulatory bodies impose strict standards that must be met, which can increase the cost and complexity of bringing new excipients to market[3].

High Development Costs

The development of new excipients, including colorants, is a costly process. High development costs can act as a barrier to entry for new manufacturers and limit the innovation in the field[3].

Financial Trajectory

Market Size and Growth

The financial trajectory of the pharmaceutical excipients market, which includes FD&C Blue No. 2, is positive. The market is expected to grow from USD 10.0 billion in 2023 to USD 13.9 billion by 2028. This growth indicates a stable and increasing demand for excipients, including colorants[3].

Certification Quantities

The certification quantities of FD&C Blue No. 2 provide insight into its market demand. For instance, in the second quarter of the fiscal year 2024, 61,262.02 pounds of FD&C Blue No. 2 were certified, indicating a significant and ongoing demand for this colorant[2].

Conclusion

The market dynamics for FD&C Blue No. 2 are influenced by the broader trends in the pharmaceutical excipients market. With a growing demand for generic drugs, patient-centric formulations, and increased R&D investments, the outlook for FD&C Blue No. 2 is positive. However, the market must navigate challenges such as regulatory stringency and high development costs.

Key Takeaways

  • Regulatory Approval: FD&C Blue No. 2 is FDA-approved for use in foods, drugs, and cosmetics.
  • Market Growth: The pharmaceutical excipients market, including FD&C Blue No. 2, is expected to grow at a CAGR of 6.8% from 2023 to 2028.
  • Applications: Widely used in various medications, including tablets and capsules.
  • Demand Drivers: Increasing demand for generic drugs, patient-centric formulations, and R&D investments.
  • Market Restraints: Stringent regulatory requirements and high development costs.

FAQs

What is FD&C Blue No. 2 used for?

FD&C Blue No. 2 is used as a colorant in drug dosage forms such as tablets and capsules, as well as in foods and cosmetics[1].

Which medications contain FD&C Blue No. 2?

Medications such as Alprazolam, Amphetamine and Dextroamphetamine Extended Release, Clonazepam, and others contain FD&C Blue No. 2[1].

What is the difference between FD&C Blue No. 2 and FD&C Blue No. 2 Aluminum Lake?

FD&C Blue No. 2 Aluminum Lake is a form of the colorant that is more stable and suitable for tablet coatings, formed by reacting the straight color with precipitants and salts[4].

How is the demand for FD&C Blue No. 2 expected to change?

The demand for FD&C Blue No. 2 is expected to increase due to the growing demand for generic drugs and patient-centric formulations[3].

What are the main challenges facing the market for FD&C Blue No. 2?

The main challenges include stringent regulatory requirements and high development costs for new excipients[3].

Sources

  1. Drugs.com: FD&C Blue No. 2: What is it and where is it used?
  2. FDA: Report on the Certification of Color Additives: 2nd Quarter, Fiscal Year 2024
  3. MarketsandMarkets: Pharmaceutical Excipients Market Growth, Drivers, and Opportunities
  4. Drugs.com: FD&C Blue No. 2 Aluminium Lake: What is it and where is it used?

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.